Teva Blends Branded And Generic Mindsets To Boost Biosimilars
US Generics COO Says Teva Is ‘Uniquely Qualified’ To Succeed In The Biosimilar Arena
Teva is “uniquely qualified” to succeed with biosimilars thanks to the dual branded and generic mindsets that it can bring to the table, Christine Baeder, senior vice president and chief operating officer of Teva’s US generics division, tells Generics Bulletin in the second part of an exclusive interview.
